|
WO2004054512A2
|
|
Therapeutic retroviral vectors for gene therapy
|
|
AU2003279240A1
|
|
Methods for purifying viral particles for gene therapy
|
|
US2004062751A1
|
|
Methods for inhibiting angiogenesis
|
|
US2003139333A1
|
|
Methods and compositions for promoting angiogenesis
|
|
WO02087341A1
|
|
Novel self-inactivating (sin) lentiviral vectors
|
|
AU2002311777A1
|
|
Method of treating arthritis using lentiviral vectors in gene therapy
|
|
WO02058718A2
|
|
Use of compositions containing pdgf-bb for promoting angiogenesis
|
|
AU6328101A
|
|
Polyethylene glycol (peg) polymers for the promotion of angiogenesis
|
|
AU6173701A
|
|
Methods and compositions for promoting angiogenesis using monocytes
|
|
AU3988799A
|
|
Novel lentiviral packaging cells
|
|
WO9926480A1
|
|
Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
|
